Location History:
- Saint Clement de Rivière, FR (2010)
- St. Clement de Riviere, FR (2011)
Company Filing History:
Years Active: 2010-2011
Title: The Innovative Contributions of Didier Lefevre
Introduction
Didier Lefevre is a notable inventor based in St. Clement de Riviere, France. He has made significant contributions to the field of biological analysis, particularly through his innovative patents. With a total of 2 patents, Lefevre's work focuses on methods and devices that enhance the characterization of cellular components in biological fluids.
Latest Patents
Lefevre's latest patents include a method and device for characterizing cellular components of a biological fluid. This invention involves a primary cytological analysis step, typically implemented by flow cytometry equipment, to differentiate and count cellular components in a sample. The method also includes a complementary step for analyzing specific cellular components based on identified peculiarities, which is particularly applicable in hematological analyses.
Another significant patent is a device and method for multiparametric analysis of microscopic elements. This device features a measuring space for analyzing microscopic elements, a source delivering conjugated rays at different analyzing wavelengths, and various means for encoding, filtering, and detecting the interacting rays. The analysis enables the determination of data representing the analyzed microscopic elements.
Career Highlights
Didier Lefevre is associated with Horiba Abx Sas, a company known for its advancements in analytical and diagnostic solutions. His work at this company has allowed him to contribute to the development of innovative technologies in the field of biological analysis.
Collaborations
Lefevre has collaborated with notable coworkers, including Philippe Nerin and Francis Lacombe. These collaborations have likely enriched his research and development efforts, leading to impactful innovations.
Conclusion
Didier Lefevre's contributions to the field of biological analysis through his patents demonstrate his commitment to advancing scientific knowledge and technology. His innovative methods and devices are poised to make a significant impact in the realm of hematological analyses and beyond.